Nancy Pelosi’s drug price bill heads to full vote; FDA proposes cancer warnings on breast implants; NIH, Gates Foundation pledge $200 million to HIV, sickle cell cures.
Former CDM chief Kyle Barich jumps from healthcare to cannabis
Biogen resurrects Alzheimer’s drug in light of new analysis; ACA premiums expected to drop next year; Novartis gene therapy Zolgensma beats sales expectations.
FDA’s first ‘modified risk’ tobacco products set precedent
Drug companies reach last-minute settlement in Ohio; Larger opioid settlement talks could resume with trial delayed; Trump urges HHS to speed drug-importation plans.